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Background: Only 4 % of hemodialysis (HD) patients survive over 25 years after their initiation of HD even in
Japan. To elucidate their clinical characteristics, we investigated their lifestyle and genetic factor. TT genotype of
methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism was reported as a high-risk factor for
cardiovascular event and poor survival in CKD patients.
Method: Seventy-eight of Japanese patients receiving HD more than 30 years were enrolled. Their daily lifestyle
and activity were evaluated with diet history questionnaires (DHQ), geriatric nutritional risk index (GNRI), and basic
activity of daily living (BADL) scores. MTHFR C677T was genotyped by PCR-restriction fragment length
polymorphism (RFLP).
Results: The mean dietary intake of energy was 30.6 ± 9.3 kcal/kg of ideal body weight (IBW), protein 1.1 ± 0.4 g/kg
of IBW and their adequacy ratios for Japanese guideline 2007 were 97.7 and 101.9 %, respectively. BADL was 90,
and daily activities were highly maintained in patients. The frequency of TT genotype was 26.9 % and it was almost
twice as that in the general population. The patients with TT genotype had lower serum folate and higher serum
homocysteine than those with the CC or CT genotypes, though there was no significant difference in dietary folate
intake among them.
Conclusion: Although the frequency of TT genotype was higher than healthy population, our patients showed
longer survival with high QOL and nutritional status. It is suggested that the proper lifestyle might overcome the
genetic risk factors in patients receiving HD.
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Increasing importance has been attached to the compli-
cation of a nutritional disorder in dialysis patients as a
risk factor that leads to a poor outcome [1]. Moreover,
many dialysis patients are in a protein-energy wasting
(PEW) state [2], and this condition has been reported to
be a factor that strongly influences the survival of elderly* Correspondence: kannoyh@tokyo-med.ac.jp
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rate after introduction of dialysis has been increasing
with advances in dialysis techniques in Japan, but the 5–
10- and 25-year survival rates are only 60.3, 36.2 and
14.1 %, respectively, and patients under long-term dialy-
sis treatment for 25 years or longer account for only 4 %
(11,802 patients) of the all dialysis patients [6]. “Long-
term” outcomes represent outcomes at around 5 years
in reports from other countries, and patients on hemo-
dialysis for a short time (less than 10 years) were investi-
gated in most studies in Japan. There have been only aicle is distributed under the terms of the Creative Commons Attribution 4.0
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were investigated in patients on hemodialysis for more
than 25 years. Moreover, it is not easy to perform a pro-
spective study of long-term outcomes, nutritional con-
dition, and nutritional management. Therefore, it is
important to clarify the nutritional condition and food in-
take of patients who have been receiving hemodialysis for
more than 25 years.
In Japan, the causes of death of dialysis patients are
heart failure (26.6 %), infection (20.3 %), malignant
tumor (9.1 %), cerebrovascular disorder (7.7 %), myocar-
dial infarction (4.4 %), and hyperkalemia (2.9 %). Cardio-
vascular diseases account for about 40 % of the causes of
death and contribute to the poor prognosis of dialysis
patients [6]. Especially, ischemic heart disease is a sig-
nificant obstacle to the maintenance of a favorable qual-
ity of life (QOL). Bachmann et al. [7] confirmed that
hyperhomocysteinemia is a risk factor for cardiovascular
disease in hemodialysis patients. Homocysteine (Hcy) is
an amino acid produced through metabolism of an essen-
tial amino acid, methionine. Dietary folate-derived 5-
methyltetrahydrofolate is required for this metabolism as
a methyl-group donor. Methylenetetrahydrofolate reduc-
tase (MTHFR) catalyzes the irreversible conversion of 5,
10-methylenetetrahydrofolate to 5-methyltetrahydrofolate.
TheMTHFR C677T polymorphisms is a C to T transition
at position 677 (exon4), which causes the substitution of
alanine with valine and leads to about 35 % decrease in
enzyme activity in CT heterozygotes and 60 % decrease in
TT homozygotes [8]. This reduced enzyme activity causes
an elevating serum Hcy level [8]. The associations of this
polymorphism to hyperhomocysteinemia and cardiovas-
cular disease have been reported. In a study reported in
Japan, frequency of T allele was 33 % and the frequency of
TT genotype was 10.2 % in Japanese population, and the T
allele frequency was higher in ischemic heart disease and
cerebral infarction patients than in normal controls. The
serum Hcy level was higher in patients with TT genotype
than in those with other genotypes, and the relationship
between Hcy and genotype was stronger in the low folate
intake [9]. The frequency of the TT genotype was 13.7 %
in a study of hemodialysis patients, and it was higher
(23.8 %) in patients with a cardiovascular disorder, show-
ing that the MTHFR polymorphism is an important factor
that influences the serum Hcy level [10, 11]. However,
there have been only a few studies of Japanese patient with
renal failure and hemodialysis patients, and the MTHFR
C677T polymorphism has not been investigated in long-
term hemodialysis patients.
This study was performed to clarify the actual nutri-
tion state and food intake of long-term hemodialysis
patients after more than 25 years of dialysis. We also in-
vestigated nutritional management during long-term
hemodialysis which is considered as a risk factor formortality, as association between MTHFR C677T poly-
morphism, which was based on the risks of renal dys-
function and introduction of dialysis.
Methods
Subjects
Ninety-five patients who had received hemodialysis for
more than 25 years or longer were selected from outpa-
tients undergoing hemodialysis three times a week at 14
institutions including Keio University Hospital and re-
lated facilities. Documents explaining the objective of
the survey and protection of personal information were
handed to the subjects, and written consent was ob-
tained from 90 patients after an explanation had been
given by physicians. Three patients with missing labora-
tory test values, one with missing dietary survey result,
one with renal transplantation, and one who died during
the survey period were excluded. Another six patients
were excluded because of extreme under/over-reporting,
which was assessed based on the method reported by
Sasaki, the developer of brief-type self-administered diet
history questionnaire (BDHQ) [12]. The exclusion cri-
teria of the dietary survey are as follows, based on the
Dietary Reference Intakes for Japanese, 2010 edition: “an
energy intake lower than 0.5 times the estimated energy
requirement for physical activity level I, and an energy
intake of 1.5 times or higher than the estimated energy
requirement for physical activity level III [13]”. Subjects
in this study finally consisted of 78 patients (31 male
and 47 females). The survey period was from March to
November in 2012.
This study was approved by Keio University School of
Medicine Ethics Committee (approval number 2011-271,
dated January 11, 2012) and Experimental Study Ethics
Committee of Kagawa Education Institute of Nutrition
(approval number 201-G, dated March 14, 2012).
Measurements
The subject characteristics (sex, age, duration of dialysis
therapy, age at the time of introduction of dialysis, and
primary disease for renal failure), physical conditions
(height, dry weight [DW], and body mass index [BMI])
were assessed. For blood chemistry, blood samples were
collected at the beginning of the first dialysis session of
the week (Monday or Tuesday) immediately before dia-
lysis, and serum albumin (Alb), blood urea nitrogen
(BUN), serum creatinine (Cr), serum potassium (K),
serum inorganic phosphorus (IP), serum calcium (Ca),
hemoglobin (Hb), hematocrit (Hct), serum folate, serum
homocysteine (Hcy), and serum vitamin B12 (VB12) were
analyzed. The concentrations of serum folate and vita-
min B12 were measured using chemiluminescent enzyme
immunoassay (CLEIA) on UniCel DxI 800 with Access
Folate and Access Vitamin B12, respectively (Beckman
Table 1 Subject characteristics
Variable Total (n = 78)
Age Years 632 ± 8.1a
Gender (Male/female) n (%) 31/47 (39.7/60.3 %)b
Duration of hemodialysis Years 305 (27.0–34.3)c
Age of initiation of hemodialysis Years 32.4 ± 8.0
Primary disease
Chronic glomerulonephritis n (%) 55 (70.5 %)
Chronic pyelonephritis n (%) 1 (1.3 %)
Nephropathy of pregnancy n (%) 3 (3.8 %)
Polycystic kidney n (%) 2 (2.6 %)
Other nephritides that
cannot be classified
n (%) 4 (5.1 %)
Other n (%) 2 (2.6 %)
Unknown n (%) 11 (14.1 %)
MTHFR C677T (CC/CT/TT) n (%) 23/34/21
(29.5/43.6/26.9 %)
Height cm 157.6 ± 8.3
Weight (dry weight) kg 46.3 (41.7–57.0)
Body mass index (BMI) kg/m2 197.7 ± 2.7
BMI < 18.5 n (male/female)
(%)
32 (7/25) (41.0 %)
18.5≦ BMI < 25 n (male/female)
(%)
42 (21/21) (53.8 %)
25≦ BMI n (male/female)
(%)
4 (3/1) (5.1 %)
Geriatric nutrition index (GNRI) 93 ± 6
≧ GNRI 91 (without risk
of malnutrition)
n (%) 46 (59.0 %)
<GNRI 91 (with risk
of malnutrition)
n (%) 32 (41.0 %)
Barthel Index (BADL) 90.0 (78–100)
BADL (independent/some
help is necessary/with help)
n (%) 74/4/3 (91/5/4 %)
Weight change rate
between dialysisd
% 5.1 ± 1.9
Kt/Vspe 1.67 ± 0.2
Biochemical parameters
Serum albumin (alb) g/dL 3.70 ± 0.3
Total protein (TP) g/dL 6.60 ± 0.4
Blood urea nitrogen (BUN) mg/dL 65.00 ± 17.1
Serum creatinine (Cr) mg/dL 10.70 ± 2.2
Urea acid (UA) mg/dL 7.10 ± 1.5
Serum sodium (Na) mEq/L 140.00 ± 2.5
Serum potassium (K) mEq/L 5.10 ± 0.7
Serum inorganic
phosphorous (IP)
mg/dL 5.40 ± 1.4
Serum calcium (Ca) mg/dL 9.10 ± 0.7
Hemoglobin (Hb) g/dL 10.30 (9.6–11.2)
Hematocrit (Hb) % 33.00 ± 3.4
Table 1 Subject characteristics (Continued)
Serum folate ng/mL 4.60 (3.8–5.4)
Serum homocystein (Hcy) μmol/L 30.80 (23.6–38.4)
Serum vitamin in B12 (VB12) pmol/L 541.00 (340–1250)
Abbreviations: ESRD end stage renal disease, MTHFR methylene tetrahydrofolate
reductase, BMI body mass index, GNRI geriatric nutrition risk index, BADL Barthel
index
aValues are means ± standard deviation (all such values)
bValues are number of all patients (%)
cValues are median (25th and 75th percentiles), (all such values)
dBody weight change rate between hemodialysis; 55 subjects with data before
and after hemodialysis. (values are means ± standard deviation)
eStandardized dialysis volume (Kt/Vsp); 55 subjects with data before and after
hemodialysis. (values are means ± standard deviation)
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high-performance liquid chromatography (HPLC). These
measurements before and after dialysis were available in
55 patients, and the index of dialysis efficiency, Kt/Vsp,
was calculated using Shinzato’s formula [14]. Blood
chemistry was analyzed by SRL Tokyo Medical (Tokyo,
Japan).
Habitual energy, nutrient, and food group intakes were
surveyed using BDHQ [15, 16] which is a simplified ver-
sion of the self-administered diet history questionnaire
(DHQ) developed by Sasaki et al. [17]. To assess activ-
ities of daily living, basic activities of daily living were
evaluated using BADL published by Mahoney and
Barthel in 1965 [18]. The geriatric nutrition risk index
(GNRI) used for nutrition screening of dialysis patients
was calculated using the formula below. GNRI is a nutri-
tion screening tool for the elderly developed by Bouillanne
et al. [19]. Yamada et al. [20] applied GNRI in a study of
dialysis patients and reported its usefulness.
DNA was extracted from EDTA-added whole-blood
samples collected as described above using a fully auto-
mated nucleic acid extraction device, Magtration® Sys-
tem 6GC, and a reagent that is used exclusively with this
device, MagDEA DNA 200 (GC) (Precision System Sci-
ence Co., Ltd., Japan). The MTHFR C677T polymorph-
ism was genotyped using polymerase chain reaction
(PCR) technique and restriction fragment length poly-
morphism (RFLP) analysis by PaGE (Tokyo, Japan). The
patients were divided into three groups based on the
MTHFR C677T genotype, and the association with each
index (physical condition, laboratory test values, food in-
take, daily living activities, and GNRI) was investigated.
Statistical analysis
Variables detected in the measurements and survey
items were confirmed using the Shapiro–Wilk test of
normality and histograms. When the distribution was
not normal, logarithmic transformation or nonparamet-
ric test was employed. Log-transformed serum Hcy was
examined using linear regression analysis. Data sets of
variables with normality were presented as means ±
Table 2 Habitual dietary intakes
Variable Total (n = 78)
Intakes of nutrients and energy
Energy kcal 1635 (1247–1993)
Energy kcal/kgIBW 29.2 (22.8–35.8)
Protein g 57.6 (44.0–72.7)
Protein g/kgIBW 1.1 (0.8–1.3)
Ratio of animal protein % 56.2 (46.1–64.0)
NPC/Na 147 (126–175)
Fat %E 27.5 (22.5–30.7)
Carbohydrate %E 56.6 (51.6–61.1)
Retinol μg 556 (398–878)
α-tocopherol mg 6.7 (5.1–8.7)
Potassium mg 1946 (1463–2586)
Calcium mg 386 (248–502)
Phosphorus mg 841 (609–1062)
Iron mg 6.6 (4.6–8.3)
VitaminB6 mg 1.0 (0.7–1.3)
VitaminB12 μg 7.1 (4.6–10.1)
Folate μg 285 (200–370)
VitaminC mg 99 (71–136)
Salt g 8.9 (7.4–10.8)
Energy-adjusted nutrient intakes
Retinol μg/1000 kcal 350 (255–490)
α-tocopherol mg/1000 kcal 4.2 (3.6–4.9)
Potassium mg/1000 kcal 1211 (1021–1469)
Calcium mg/1000 kcal 225 (179–294)
Phosphorus mg/1000 kcal 523 (453–599)
Iron mg/1000 kcal 4.0 (3.4–4.6)
VitaminB6 mg/1000 kcal 0.6 (0.5–0.7)
VitaminB12 μg/1000 kcal 4.5 (3.2–6.4)
Folate μg/1000 kcal 169 (137–219)
VitaminC mg/1000 kcal 64 (44–77)
Salt g/1000 kcal 5.5 (4.9–6.3)
Energy-adjusted food group intakes
Cereals g/1000 kcal 220 (185–297)
Potatoes g/1000 kcal 18 (8–43)
Sugar and confectioneries g/1000 kcal 2.9 (1.7–3.7)
Nuts and pulses g/1000 kcal 18 (8–28)
Green and yellow vegetables g/1000 kcal 52 (32–79)
Other vegetables g/1000 kcal 68 (49–101)
Fruits g/1000 kcal 43 (18–85)
Fish and shellfish g/1000 kcal 39 (24–54)
Meat g/1000 kcal 35 (25–52)
Eggs g/1000 kcal 18 (7–31)
Daily products g/1000 kcal 24 (7–64)
Table 2 Habitual dietary intakes (Continued)
Fats and oils g/1000 kcal 6.4b (4.4–8.6)
Confectioneries g/1000 kcal 24 (13–50)
Alcoholic beverages and
non-alcoholic beverages
g/1000 kcal 212 (138–336)
Seasoning and spice g/1000 kcal 81 (53–139)
All values are median (25–75percentiles)
aNPC/N, Ratio of non-protein energy/nitrogen
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presented as medians (25th and 75th percentiles). Re-
garding food intake, the measured energy intake, animal
protein ratio, lipid energy ratio, iron intake, and energy-
adjusted potassium and B6 intakes showed normal distri-
butions, but the others did not. Since the median and
mean are similar when the distribution is normal, all data
were presented as medians (25th and 75th percentiles).
In the comparison of the three MTHFRC 677T
genotype-based groups (CC, CT, and TT groups), the
interval and ratio scales were compared using one-way
analysis of variance and multiple comparison (homoge-
neous variance: Tukey’s test; non-homogeneous variance:
Games–Howell test), or the Kruskal–Wallis test and mul-
tiple comparison (Bonferroni correction; Mann–Whitney
U test). For the nominal scale, the χ2 test was employed.
Statistical analysis was performed using a statistical
package, IBM SPSS Statistics Ver. 20 (IBM, Tokyo), and
the significance level was set at less than 5 %. When a




The characteristics, physical condition, and
biochemical parameters of the study subjects were
shown in Table 1.
The mean score of the nutritional disorder risk
index, GNRI, was 93 ± 6, and the percentage of
patients with a nutritional disorder risk with a GNRI
score of less than 91 was 41.0 %.
2. Habitual dietary intakes
The median (25th and 75th percentiles) daily habitual
energy, nutrient, energy-adjusted nutrient, and food
group intakes of the patients are shown in Table 2.
3. Adequacy ratio for “Dietary recommendations for
chronic kidney disease (CKD), 2007 (guidelines) [21]”.
The energy, protein, potassium, and phosphorus
intake sufficiency rates were 97.7, 101.9, 103.6, and
96.7 %, respectively, which met the recommendations
of the guidelines, but the salt intake sufficiency rate
was 152.6 %, indicating excessive ingestion, and only
12.8 % of patients met the recommendation of less
than 6 g/day.
Table 3 Clinical characteristics of patients (MTHFR C677T genotype)
Genotype
Variable CC CT TT
(n = 23) 29.5 % (n = 34) 43.6 % (n = 21) 26.9 % P value
Age years 62.7 ± 6.9a 63.6 ± 8.7 63.2 ± 8.7 0.920
Gender(Male/Female) n 11/12 10/29 10/11 0.261
Duration of hemodialysis years 28.0 (25.0-31.0)b 31 (27.0-34.3) 32.0 (28.5-35.0) 0.276
Age at initiation of hemodialysis years 33.0 ± 7.3 32.7 ± 8.5 31.3 ± 8.2 0.760
Height cm 159.7 ± 9.1 155.7 ± 8.1 158.5 ± 7.5 0.170
Dry weight(DW) kg 50.0d (43.8-59.5) 44.0e (39.1-50.9) 52.6d (44.5-59.3) 0.014*
Body mass index(BMI) kg/m2 20.2 ± 19.7 18.8 ± 2.8 20.5 ± 2.6 0.050
BMI<18.5 n (%) 7 (21.9 %)c 19 (59.4 %) 6 (18.8 %)
18.5≦BMI<25 n (%) 15 (35.7 %) 14(33.3 %) 13 (31.0 %)
25≦BMI n (%) 1 (25.0 %) 1 (25.0 %) 2 (50.0 %)
Bathel Index(BADL) 90 (74-100) 98 (84-100) 85 (78-100) 0.253
BADL(independent/some help is necessary/with help) n 20/2/1 33/1/0 18/1/2 <0.001*
Geriatric nutrition risk index(GNRI) 9489-90 9088-96 9491-99 0.200
≧GNRI 91(without risk of malnutrition) n(%) 16 (34.8 %) 15 (32.6 %) 15 (32.6 %)
<GNRI 91(with risk of malnutrition) n(%) 7 (21.9 %) 19 (59.4 %) 6 (18.8 %)
Biochemical parameter
serum albumin (Alb) g/dL 3.7 ± 0.3 3.8 ± 0.3 3.7 ± 0.3 0.887
total protein (TP) g/dL 6.4d ± 0.3 6.6 ± 0.5 6.7e ± 0.5 0.045*
blood urea nitrogen (BUN) mg/dL 63.8 ± 14 64.2 ± 6.6 67.6 ± 21.2 0.718
serum creatinine (Cr) mg/dL 10.8 ± 2.3 10.5 ± 2.2 10.8 ± 2.2 0.873
urea acid (UA) mg/dL 7.1 ± 1.3 6.9 ± 1.7 7.5 ± 1.5 0.341
serum sodium (Na) mEq/L 141 ± 2 140 ± 2.6 140 ± 2.9 0.847
serum potassium (K) mEq/L 5.1 ± 0.6 5.2 ± 0.7 5.1 ± 0.6 0.864
serum inorganic phosphorus (IP) mg/dL 5.7 ± 1.1 5.1 ± 1.2 5.6 ± 1.8 0.164
serum calcium (Ca) mg/dL 8.9 ± 0.7 9.3 ± 0.7 9 ± 0.6 0.096
Hemoglobin (Hb) g/dL 10.4 (9.1-11.5) 10.3 (10.1-11.7) 10.2 (9.5-11.1) 0.789
Hematocrit (Ht) % 33.5 ± 4.3 32.9 ± 3.3 32.7 ± 2.9 0.164
serum folate ng/mL 4.7d (4.3-5.6) 4.7d (3.8-6.0) 3.9e (3.2-4.5) 0.005*
serum homocystein (Hcy) μmol/L 30.5d (25.2-37.6) 25.1d (22.1-36.9) 35.4e (27.3-58.3) 0.029*
serum vitaminB12 (VB12) pmol/L 545 (314-1200) 630 (383-1328) 456 (291-1463) 0.763
Abbreviations: MTHFR Methylene tetrahydrofolate reductase, BMI body mass index, GNRI geriatric nutrition risk index, BADL Barthel index
aValues are means ± Standard deviation(all such values)
bValues are median(25th and 75th percentiles)(all such values)
cValues are number of all patients (%)
The normality of the data was first assessed using the Shapiro-Wilks test
The values are compared between the groups by the χ2 test, one-way analysis of variance and Tukey's multiple comparison test of or Games-Howell's test, and
Kruskal-Wallis test and Bonferroni's multiple comparison test as appropriate. *p < 0.05
d-eMultiple comparison; A different alphabet shows that there is a significant difference
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The frequencies of MTHFR C677T genotype were
29.5, 43.6, and 26.9 % for CC, CT, and TT
genotypes, respectively. This showed that the
frequency of TT type was significantly higher than
that in Japanese hemodialysis patients as reported by
Morimoto et al. (13.7 %) [11] and Kimura et al.
(17.4 %) [22] (P < 0.05), and this was alsosignificantly higher than that in healthy Japanese
(about 15 %) [23, 24] (P < 0.05).
5. Activities of daily living
The median score of BADL, which evaluates the
performance of activities of daily living, was 90
(range, 78–100). Notably, 91 % of subjects were
“independent” while 5 % “required partial assistance”
and 4 % “required assistance”.
Table 4 Nutrient intakes and food group intakes of subjects with 3 different genotype of MTHFR C677T polymorphism
Variable CC(n = 23)29.5 % CT(n = 34)43.6 % TT(n = 21)26.9 % P value
Energy kcal 1897 (1299-2283) 1452 (1158-1812) 1584 (1365-1945) 0.088
Energy kcal/kgIBW 33.0 (23.5-40.0) 27.6 (21.6-34.7) 30 (23.7-34.6) 0.155
Protein g 62.2b (49.4-85.2) 49.7c (38.5-66.6) 58.9 (42.6-72.6) 0.036*
Protein g/kgIBW 1.1 (1.0-1.6) 0.9 (0.8-1.3) 1.1 (0.8-1.2) 0.086
ratio of animal protein % 58 (52-63) 54 (42-66) 55 (43-63) 0.332
NPC/Na 144 (126-154) 147 (129-191) 152 (120-200) 0.383
Fat %E 28.5 (26.2-33.2) 27 (21.5-30.5) 23.7 (19.5-29.8) 0.067
Carbohydrate %E 54.8 (51.7-57.2) 57.6 (50.7-65.8) 57.9 (54.0-64.3) 0.210
Retinol μg 620 (457-1143) 538 (328-791) 552 (371-828) 0.184
α-tocopherol mg 8.2b (6.0-10.4) 5.8c (4.3-7.4) 6.8 (5.0-8.7) 0.025*
Potassium mg 2069 (1539-2945) 1802 (1359-2185) 2104 (1541-2618) 0.208
Calcium mg 398 (290-573) 373 (230-473) 386 (249-476) 0.399
Phosphorus mg 987 (677-1212) 725 (577-998) 847 (657-1048) 0.073
Iron mg 7.7 (5.7-9.0) 6.0 (4.2-8.1) 6.5 (4.2-8.1) 0.114
VitaminB6 mg 1.0 (0.8-1.5) 0.9 (0.7-1.2) 1.0 (0.8-1.5) 0.157
VitaminB12 μg 8.4 (6.7-12.2) 6.5 (3.8-9.8) 5.4 (4.3-11.2) 0.123
Folate μg 285 (219-436) 279 (183-364) 285 (183-368) 0.465
VitaminC mg 100 (73-166) 93 (71-119) 103 (51-137) 0.475
Salt g 10.3b (8.7-12.0) 7.6c (6.4-9.7) 9.3d (7.8-11.3) 0.001*
Retinol μg/1000 kcal 366 (237-556) 350 (266-492) 329 (235-461) 0.519
α-tocopherol mg/1000 kcal 4.3 (3.9-5.1) 4.2 (3.5-4.8) 4.2 (3.2-5.3) 0.476
Potassium mg/1000 kcal 1220 (1014-1373) 1211 (1075-1469) 1210 (936-1558) 0.992
Calcium mg/1000 kcal 250 (185-292) 227 (184-300) 222 (164-292) 0.359
Phosphorus mg/1000 kcal 543 (496-588) 516 (434-628) 486 (405-647) 0.614
Iron mg/1000 kcal 4 (3.5-4.5) 4.3 (3.6-4.6) 3.7 (3.0-4.7) 0.407
VitaminB6 mg/1000 kcal 0.6 (0.50-0.70) 0.7 (0.50-0.73) 0.6 (0.50-0.80) 0.969
VitaminB12 μg/1000 kcal 4.7 (4.0-5.7) 4.5 (3.0-6.2) 4.2 (2.7-6.7) 0.609
Folate μg/1000 kcal 165 (138-219) 190 (153-223) 164 (113-212) 0.445
VitaminC mg/1000 kcal 60 (47-81) 64 (49-77) 65 (32-70) 0.808
Salt g/1000 kcal 5.7 (5.2-6.4) 5.3 (4.5-6.2) 5.4 (4.4-6.5) 0.164
Cereals g/1000 kcal 201 (184-284) 220 (187-297) 230 (185-318) 0.638
Potatos g/1000 kcal 12 (7-44) 17 (7-41) 31 (10-53) 0.303
Sugar and confectioneries g/1000 kcal 3.5 (1.8-4.5) 2.3 (1.6-3.2) 3.2 (1.7-3.6) 0.149
Nuts and pulses g/1000 kcal 19 (11-29) 19 (11-29) 16 (6-29) 0.522
Green and yellow vegetables g/1000 kcal 51 (27-65) 62 (42-83) 49 (26-78) 0.343
Other vegetables g/1000 kcal 65 (49-100) 73 (44-101) 80 (49-119) 0.933
Fruits g/1000 kcal 51 (32-107) 32 (15-67) 50 (17-86) 0.197
Fish and shellfish g/1000 kcal 44 (26-51) 37 (21-52) 41 (20-60) 0.717
Meat g/1000 kcal 42 (29-70) 31 (18-50) 36 (25-47) 0.087
Eggs g/1000 kcal 24b (11-35) 17 (6-28) 8c (4-21) 0.028*
Daily products g/1000 kcal 28 (9-47) 25 (8-73) 16 (0-61) 0.380
Fats and oils g/1000 kcal 7.5 (5.4-9.7) 5 (3.7-7.)8 6.5 (5.8-8.7) 0.055
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Table 4 Nutrient intakes and food group intakes of subjects with 3 different genotype of MTHFR C677T polymorphism (Continued)
confectioney g/1000 kcal 23 (12-46) 24 (12-52) 24 (14-48) 0.962
Alcoholic bevarages and Non-Alcoholic bevarage g/1000 kcal 176 (114-304) 207 (143-408) 246 (154-399) 0.401
seasoning and spice g/1000 kcal 81 (61-150) 82 (51-135) 61 (36-121) 0.281
Abbreviations: MTHFR methylenetetrahydrofolate reductase
aNPC/N ratio of non-protein energy per nitroden
All values are median (25th and 75th percentiles)
The normality of the data was first assessed using the Shapiro-Wilks test
The values are compared between the groups by Kruskal-Wallis test and Bonferroni's multiple comparison test as appropriate. *p < 0.05
b-cMultiple comparison; A different alphabet shows that there is a significant difference
Table 5 Pearson's correlation coefficients between serum
homocystein and laboratory test values
(n = 77)
r P value
Age year -0.112 0.382
Gender -0.237 0.038*
Duration of hemodialysis year -0.072 0.568
Age at initiation of hemodialysis year -0.074 0.524
MTHFR C677T -0.249 0.029*
Height cm 0.179 0.119
Weight(dry weight) kg 0.205 0.073
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polymorphism
The characteristics of patients, the physical condition, bio-
chemical parameters and dietary intake, according the
MTHFR C677T genotypes (CC, CT, and TT), are shown
in Tables 3 and 4. No significant differences were observed
in age, duration of dialysis therapy, age at the introduction
of dialysis, physical condition, BADL or GNRI among the
different genotypes. There were significant differences in
TP (P = 0.045), serum folate (P = 0.005), and serum Hcy
(P = 0.029), among the genotypes. The serum folate level
was significantly lower and the serum Hcy level was sig-
nificantly higher in the subjects with TT genotype than in
those CC and CT genotypes. No significant differences
were present in serum Alb, BUN, Cr, K, IP, Hb, Ht, and
VB12 among the genotypes.
Regarding dietary intake, no significant differences
were observed in the energy or protein intake per kg
IBW, animal protein ratio, NPC/N, lipid energy ratio, or
carbohydrate energy ratio, nor were there significant dif-
ferences in the energy-adjusted potassium, phosphorus,
folate, vitamin B6, or B12 intake among the genotypes.BMI kg/m2 0.139 0.227
GNRI 0.330 0.003*
BADL 0.035 0.760
serum albumin g/dL 0.271 0.017*
blood urea nitrogen (BUN) mg/dL 0.040 0.732
serum creatinine (Cr) mg/dL 0.200 0.081
urea acid (UA) mg/dL 0.211 0.065
serum sodium (Na) mEq/L 0.081 0.486
serum potassium (K) mEq/L 0.026 0.822
serum inorganic phosphorus (IP) mg/dL 0.334 0.003*
serum calcium (Ca) mg/dL -0.088 0.445
Hemoglobin (Hb) g/dL 0.071 0.541
Hematocrit (Ht) % -0.025 0.830
serum folate ng/mL -0.384 0.001*
serum homocystein (Hcy) pmol/L -0.495 <0.001*
Abbreviations: MTHFR methylenetetrahydrofolate reductase, BMI body mass
index, GNRI geriatric nutrition risk index, BADL Barthel index
Data not regularly distributed were log transformed for futher statistical
analysis. *P < 0.05
Adjusted for gender, ageAssociations between the serum Hcy level and physical
condition, biochemical parameters, and food intakes
The results of analysis of correlations between the serum
Hcy level and physical condition, biochemical parame-
ters and food intake are shown in Tables 5 and 6. No
correlation was observed between the serum Hcy level
and age, duration of dialysis therapy, BMI or BADL. A
positive significant correlation was noted with GNRI
(r = 0.33, P = 0.003). Regarding the association with
biochemical parameters, positive correlations were
noted with serum Alb (r = 0.271, P = 0.009) and IP (r =
0.334, P = 0.002) levels, and inverse correlations were
noted with serum folate (r = −0.384, P < 0.001) and serum
VB12 (r = −0.495, P < 0.001) levels. Regarding the associ-
ation with food intake, inverse correlations were noted
with animal protein ratio (r = −0.252, P = 0.013), energy-
adjusted vitamin B6 intake (r = −0.192, p = 0.048), and B12
intake (r = −0.242, P = 0.017). No correlation was noted
with energy-adjusted food group intakes.Factors that may influence the serum Hcy level
The serum Hcy level was analyzed after testing the nor-
mality of the variable using the Shapiro–Wilk test and
confirming the distribution by examining the histogram,
followed by logarithmic transformation. To investigate
factors influencing the serum Hcy level, the correlation
matrix was examined with serum Hcy level as a response
variable, but no variable with |r| > 0.9 was present. Thus,
multiple regression analysis was performed employing
the stepwise method, mainly regarding factors with
Table 6 Peason's correlation coefficients between serum
homocystein consentration and dietary intake
(n = 77)
r P value
Energy kcal/kgIBW -0.062 0.592
Protein g/kgIBW -0.149 0.194
ratio of animal protein % -0.252 0.027*
NPC/Na 0.176 0.125
Fat % -0.135 0.241
Carbohydrate % 0.191 0.097
Potassium mg -0.103 0.372
Calcium mg -0.164 0.153
Phosphorus mg -0.110 0.342
Iron mg -0.100 0.388
VitaminB6 mg -0.101 0.382
VitaminB12 μg -0.207 0.071
Folate μg -0.090 0.435
Salt g -0.092 0.425
Energy-adjusted nutrient intakes
Potassium mg/1000 kcal -0.127 0.272
Calcium mg/1000 kcal -0.165 0.152
Phosphorus mg/1000 kcal -0.175 0.127
Iron mg/1000 kcal -0.137 0.236
VitaminB6 mg/1000 kcal -0.192 0.095
VitaminH12 μg/1000 kcal -0.242 0.034*
Folate μg/1000 kcal -0.093 0.422
Salt g/1000 kcal -0.151 0.19
Energy-adjusted food group intakes
Cereals g/1000 kcal 0.164 0.155
Potatoes g/1000 kcal 0.136 0.239
Sugar and confectioneries g/1000 kcal 0.010 0.932
Nuts and pulses g/1000 kcal -0.062 0.590
Green and yellow vegetables g/1000 kcal -0.041 0.726
Other vegetables g/1000 kcal -0.080 0.492
Fruits g/1000 kcal -0.187 0.104
Fish and shellfish g/1000 kcal -0.095 0.413
Meat g/1000 kcal -0.109 0.346
Eggs g/1000 kcal -0.147 0.202
Daily products g/1000 kcal -0.109 0.347
Fats and oils g/1000 kcal -0.092 0.426
Confectioneries g/1000 kcal 0.403 0.403
Alcoholic beverages and
Non-Alcoholic beverage
g/1000 kcal 0.138 0.231
seasoning and spice g/1000 kcal 0.009 0.941
aNPC/N, ratio of non-protein energy per nitrogen
Data not regularly distributed were log transformed for further statistical
analysis. *p < 0.05
Adjusted for gender, age
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results are shown in Table 7.
On analysis using age and sex as adjustment factors,
factors influencing the serum Hcy level were the serum
VB12, folate, and IP levels as well as animal protein intake
ratio and serum Alb level. The results in the analysis of
variance table was significant (P < 0.001) with R2 = 0.552
and adjusted R2 = 0.513. The Durbin–Watson ratio was
1.716, being non-problematic, and there was no outlying
predicted value exceeding ±3SD of the measured value.
Discussion
In this study, the actual state of nutritional management
of long-term hemodialysis patients was investigated at
first. Nutritional management contributed to the main-
tenance of a high quality of life for these long-term
hemodialysis patients, i.e., high level of independence in
ADL was maintained. In particular, it was clarified that
the influence of MTHFR C677T polymorphism—which
has attracted international attention as a risk gene for
cardiovascular disease that were major reasons for poor
outcome in hemodialysis patient could be overcome.
Regarding nutritional condition, mean BMI was 19.7 ±
2.7 kg/m2, mean serum Alb level was 3.7 ± 0.3 g/dL, and
median GNRI was 93 ± 6. Since the reported BMI of
Japanese hemodialysis patients is 21.4 ± 4.1 kg/m2 [5],
their nutritional condition was favorable.
The frequencies of CC, CT, and TT genotypes of
MTHFR C677T were 29.5, 43.6, and 26.9 %, respectively,
and the frequency of TT genotype was significantly higher
than the frequency of that in Japanese hemodialysis pa-
tients as reported by Morimoto et al. (13.7 %) [11] and
Kimura et al. (17.4 %) [22] and healthy Japanese (about
15 %) [23, 24]. Many studies reported thatMTHFR C677T
polymorphism is a risk factor for nephropathy, and a sig-
nificantly high frequency of the TT genotype in nephro-
pathy patients was also detected in a meta-analysis
conducted by Yang et al. [25]. Similar results were ob-
tained in studies of Asians reported by Sun et al. [26] and
Mtiraoui et al. [27]. In studies of Japanese hemodialysis
patients, Kimura et al. [22] investigated the association
between MTHFR C677T and hyperhomocysteinemia,
and Morimoto et al. [11] investigated MTHFR C677T,
hyperhomocysteinemia, and risk of cardiovascular dis-
ease, but they did not investigate whether the poly-
morphism is a risk factor for nephropathy. However,
they investigated the genotype frequency of MTHFR
C677T in hemodialysis patients, and the frequency of the
TT genotype was similar to those reported by Sun et al.
[26] and Mtiraoui et al. [27]. The TT genotype have been
reported as a risk factor for cardiovascular disease by
Morimoto et al. [11], and for death in end-stage renal fail-
ure patients by Jamison et al. [28], which cannot be ex-
plained by the results of our study. It was assumed that
Table 7 Multiple regression analyses to test the effects of serum components on serum homocysteine concentration
Response variable; serum Hcy
Explanatory variable Standardized partial regression coefficient (β) Standard error P value 95 % confidential interval
Serum albumin (g/dL) 0.228 0.048 0.007 0.037 0.229
Serum inorganic phosphorus (mg/dL) 0.242 0.012 0.006 0.009 0.056
Serum folate (ng/mL) −0.351 0.007 <0.0001 −0.043 −0.015
Serum VitaminB12 (pmol/L) −0.367 0.0001 <0.0001 0 0
Ratio of animal protein (%) −0.213 0.001 0.016 −0.005 −0.001
R = 0.743 R2 = 0.552
Multiple regression analyses by stepwise method
Adjusted for gender, age
Explanatory variable; MTHFRC677T, BMI, GNRI, serum potassium, energy intake (kcal/kgIBW), protein intake (g/kgIBW), energy-adjusted potassium intake, energy-
adjusted phosphate intake, energy-adjusted vitaminB6, B12 intake, energy-adjusted folate intake
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tion of dialysis was higher than the reported frequency be-
cause the duration of dialysis therapy was 7–10 years in
the reports described above, which was far shorter than
that in our study. Serum folate (5-methyltetrahydrofolate)
decreases with the TT genotype because of a 70 % de-
crease in the MTHFR enzyme activity level compared with
the activity with the CC genotype, which inhibits the path-
way of conversion of homocysteine to methionine and
elevates the serum Hcy level. Hyperhomocysteinemia pro-
motes renal dysfunction, as reported by Wollesen et al.
[29]. It has also been reported that the prevalence of hy-
perhomocysteinemia is high in hemodialysis patients, and
hyperhomocysteinemia is also a risk factor for death. Simi-
larly, hyperhomocysteinemia was noted in most patients
(96 %) in our study. The physical condition, biochemical
parameters, and dietary intake were compared among the
MTHFR C677T genotypes to clarify the influence of this
polymorphism. No significant differences in age, duration
of dialysis therapy, age at introduction of dialysis, BMI,
serum Alb level, or GNRI among different genotypes were
noted. BADL was also not significantly different, and the
percentages of independent patients were high with each
genotype. Two of three patients “requiring assistance” har-
bored the TT genotype, but as described above, they were
elderly, the duration of dialysis therapy was long (38 years)
and they were independent in their activities of daily liv-
ing, although some patients used a wheelchair. There were
no significant differences in nutrient or food group
intake among the different genotypes. The energy,
protein, potassium, and phosphorus intakes met the
nutritional levels recommended in the guidelines in
all three genotypes. The salt intake of patients mark-
edly exceeded the amount specified in the guidelines,
indicating excessive consumption. However, their body
weight was controlled, based on the examination of
body weight changes between dialysis sessions. As re-
ported by several preceding studies, the serum folate
level was low and the serum Hcy level was high with
the TT genotype. In addition, folate and vitamin B12intakes met the Dietary Reference Intakes of Japanese
dietary recommendations, while vitamin B6 was
slightly insufficient. Based on these findings, although
the serum folate and Hcy levels were influenced by
the genetic polymorphism, nutritional management
was appropriate.
Four limitations of this study exist. First, the sample
size was small, and investigation of sex differences was
not performed. Second, the causal relationships between
the factors influencing the serum Hcy level could not be
identified because this was a cross-sectional study. Third,
the dietary survey was capable of investigating habitual
food intake over 1 month, but it is unclear whether the
same pattern of food intake was maintained over a long
period after introduction of dialysis. Fourth, the study re-
sults are not applicable to the present hemodialysis pa-
tients in Japan because diabetic nephropathy patients
were absent in this study. Fifth, this is not a comparative
study, the impact of some items that investigated in this
study cannot be able to evaluate exactly. This study might
be just a presentation of clinical and genetic profile of
Japanese long-term dialysis patients.
A positive result was obtained in most studies that
examined the association between serum Hcy level and ar-
teriosclerotic disease. It has been clarified that hyperho-
mocysteinemia is a predictive factor for high mortality
that is independent of other risk factors in coronary
arterial disease patients [30]. Hyperhomocysteinemia
was shown to be an independent risk factor in a
study of 750 vascular disease patients at 19 institu-
tions in 9 European countries [31]. It was also shown
to be a strong cardiovascular disease risk factor in
non-insulin dependent diabetes patients [32]. These
findings are of interest with regard to the synergistic
effect of risk factors. Inverse correlations of folate and
vitamin B12 levels with serum Hcy level in healthy
subjects [23] have been reported, as well as the de-
crease in serum Hcy level after increased ingestion of
these vitamins, but it remains to be investigated whether
these findings are applicable to hemodialysis patients.
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In conclusion, it is natural that the frequency of the TT
genotype of MTHFR C677T was very high (26.9 %) in
patients because the TT genotype is a risk factor for
renal failure and there might be many patients with the
TT genotype at the time of introduction of dialysis.
However, the frequency of the TT genotype was not high
in long-term dialysis patients in preceding studies be-
cause the mortality rate during dialysis therapy was high
with the TT genotype. The results of our study suggested
that appropriate nutritional management decreases the
high mortality rate in patients with the TT genotype.
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